Investigational antipsychotic treatment offers sustained benefits for people with dementia-related p …

investigational antipsychotic treatment offers sustained benefits for people with dementia related psychosis

Sumary of Investigational antipsychotic treatment offers sustained benefits for people with dementia-related psychosis:

  • Pimavanserin works by blocking serotonin 5HT2A receptors, and doesn’t interact with the dopamine receptors.
  • Currently used antipsychotics are known to cause harms, and best practice guidelines recommend prescribing for no longer than 12 weeks for people with dementia as a result.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close